Navigating the Future of MedTech through Advanced Technology

This webinar is a panel discussion focused on the impact of AI, robotics, and AR/VR within the medical technology industry. With experts in their respective fields in the industry, we share how established and emerging technologies have seen different paths of evolution over time and how they continue to shape the future of MedTech.

We’re joined by Kelly Sager and Riddhit Mitra, to share their perspectives on how technology and the healthcare fields continue to impact one another. Kelly, from her work with emerging tech in clinical decision support, and Riddhit, from his work with evolving robotic technology, as well as our very own Stephanie Menard, who previously worked in the implementation of medical technology, share their perspectives on the future of MedTech. The panel is moderated by David Levine, our senior VP of client solutions for our MedTech business development division, who has helped build lasting relationships with our customers in the MedTech space.

Speaker bios:

Riddhit Mitra is the current Global Director of Product Management at Smith+Nephew. Prior to that, he has held positions of Senior Global Product Manager-Robotics and Product Manager at Smith+Nephew. Riddhit also has experience working for Blue Belt Technologies as a product manager and mechanical engineer. He received his master’s degree from Carnegie Mellon University and bachelor’s in engineering from Manipal Institute of Technology. Throughout his career, Riddhit has published papers on the value of precision and accuracy with robotics in the space of orthopedics as well as filed patents on inventions that help in orthopedic robotic surgery. At Smith+Nephew, he is responsible for the expansion of handheld robotics to global markets. He contributed to the development of hand-held precision milling NAVIO robotics for total knee arthroplasty which improved the accuracy of bone preparation and limb alignment using Surgical navigation.

Kelly Sager is Vice President and General Manager, Clinical Decision Support Solutions at Beckman Coulter Diagnostics, a Danaher operating company. In this role, Kelly is building and leading a team to deliver AI/ML-based clinical decision support (CDS) solutions to clinicians. Prior to joining Beckman, Kelly was at Becton Dickinson where she led the creation of a new business unit and the launch of a first-of-its-kind EHR-integrated medication safety solution, BD Intelliport. She has 20 years of experience in electronic health records, health information exchange, and EHR-integrated medical devices, spanning functional leadership roles in software engineering, marketing, and general management. Prior to BD, Kelly worked at MedImage, Inc., GE Healthcare, and Hospira. Kelly holds a BS in Computer Science from the University of Michigan and an MBA in Marketing Management from Northwestern University.

Stephanie Menard joined OSG as Vice President, Business Development for our Med Tech team, working as a trusted advisor to clients. Prior to OSG, Stephanie worked at Philips for 11 years in various sales roles most recently as a Key Account Executive for internet dealers where she managed internet distributor sales while promoting brand awareness through marketing-driven campaigns. Prior to Key Accounts, Stephanie had the role of Strategic Account Manager where she lead a consultative, solution-based selling approach to expand business opportunities. Taking a territory of $4mm to $12MM over her time as an account manager, she tripled her revenue, gained and maintained 80% of the capital sales market share, and had the largest single sale of one product in the product history. Stephanie received a B.A. in Psychology from Oregon State University and an MBA from Fox School of Business, Temple University. Stephanie is also a US Veteran.

David J. Levine is a Vice President of Client Solutions at OSG where he works closely with Fortune 500 clients to answer their most challenging business questions through custom-designed market research and other fact-based approaches. While he covers the full range of clients and projects at OSG, he has developed considerable expertise in medical devices and is the go-to leader in pricing strategy. David has an MBA from the Leonard M. Stern School of Business at New York University, where he specialized in Marketing and Finance. During business school, he interned in Brand Management for Novartis Consumer Health, where he worked on marketing the Excedrin brand. Prior to Stern, he spent three years working intensely with an entrepreneur/inventor to bring his first line of products from concept to market, which involved solving a number of engineering challenges, sourcing a supply chain, and developing the visual identity of the brand.